Page last updated: 2024-11-04

vorinostat and Addiction, Opioid

vorinostat has been researched along with Addiction, Opioid in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liang, DY1
Li, X1
Clark, JD1

Other Studies

1 other study available for vorinostat and Addiction, Opioid

ArticleYear
Epigenetic regulation of opioid-induced hyperalgesia, dependence, and tolerance in mice.
    The journal of pain, 2013, Volume: 14, Issue:1

    Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Blotting, We

2013